Four metre gait speed (4MGS) predicts mortality and hospitalisation in IPF

C. Nolan (London, United Kingdom), M. Maddocks (London, United Kingdom), T. Maher (London, United Kingdom), S. Jones (London, United Kingdom), S. Patel (London, United Kingdom), R. Barker (London, United Kingdom), P. George (London, United Kingdom), P. Cullinan (London, United Kingdom), W. Man (London, United Kingdom)

Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias
Session: Clinical news in idiopathic interstitial pneumonias
Session type: Oral Presentation
Number: 541
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Nolan (London, United Kingdom), M. Maddocks (London, United Kingdom), T. Maher (London, United Kingdom), S. Jones (London, United Kingdom), S. Patel (London, United Kingdom), R. Barker (London, United Kingdom), P. George (London, United Kingdom), P. Cullinan (London, United Kingdom), W. Man (London, United Kingdom). Four metre gait speed (4MGS) predicts mortality and hospitalisation in IPF. 541

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Decline in 4-metre gait speed (4MGS) over 6 months is associated with mortality in IPF.
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019

Twelve-minute walking distance predicts COPD mortality
Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation
Year: 2012

Why do COPD patients improve six minute walking distance (6MWD) with the use of a rollator?
Source: Eur Respir J 2003; 22: Suppl. 45, 330s
Year: 2003

Performance of the 4 meter gait speed test (4MGS) compared to the 6 meters walk test (6MW) in lung pathology
Source: International Congress 2019 – Cardiopulmonary exercise testing
Year: 2019


Should we use gait speed in COPD, FEV1 in frailty and dyspnoea in both?
Source: Eur Respir J 2016; 48: 315-319
Year: 2016


Repeated desaturation in 6 minute walk test increases risk for mortality in COPD patients
Source: International Congress 2017 – COPD: risk factors and prognosis
Year: 2017



Six minute walk testing components as predictors of mortality in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 14s
Year: 2004

Effect of non invasive ventilation (NIV) on stair climbing and 6 minute walking tests in severe COPD
Source: Annual Congress 2009 - Novel insights in exercise physiology from cells to humans
Year: 2009


The effect of obesity on dyspnea, 6 minute walk distance, walk work and workload in patients with COPD
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017

Air travel and COPD: Exercise SpO2 and walking distance as predictors for in-flight desaturation
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Year: 2011

6-minute walk test (6MWT) and Sit-to-Stand Test (STST) as outcome parameters in pulmonary rehabilitation (PR) of COPD patients
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015

The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference
Source: Eur Respir J 2014; 43: 1298-1305
Year: 2014



Determinants of the 6 minute walking distance and exercise desaturations in COPD: relationships with comorbidities
Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases
Year: 2017

Relationship between IL-6 and FEV1 interaction and six minute walk distance (6MWD) performance in COPD patients
Source: Annual Congress 2008 - Physiological response to exercise performance
Year: 2008


Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008


Multivariables added to walked distance during 6-min walk test (6MWT) can predict the maximal oxigen consumption (Vo2max) in end-stage renal disease patients
Source: Eur Respir J 2004; 24: Suppl. 48, 405s
Year: 2004

Six minute walking test in chronic respiratory failure: Which reflects the patient clinic status, walking distance or %predicted value?
Source: Annual Congress 2012 - The latest insights in chronic care
Year: 2012

Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015

Oxygen desaturation during a 6-min walk identifies a COPD phenotype with an increased risk of morbidity and mortality
Source: Eur Respir J 2016; 48: 1-2
Year: 2016


Effects of exercise training on quality of life and 6 minute walk distance (6MWD) in adults with fixed airway obstruction asthma (FAOA)
Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing
Year: 2008